EU
Novigenix-Led Consortium Awarded Up to €1M to Develop Predictive Immune Checkpoint Inhibitor Test
Earlier this year, Novigenix and collaborators were awarded up to €1 million to develop a blood-based multi-omics colorectal cancer assay.
The new multinational consortium, backed by the EU and Canada, seeks to improve understanding of immune responses and uncover new therapeutic targets.
Immunological Data Sharing Consortium Wins €8.4M Award From EU, Canada
The new, multinational iReceptor Plus Consortium will develop a platform for sharing of AIRR-seq data to advance immunotherapy and precision medicine.